title: [Drug treatment of angina pectoris. Study Group on Angina Pectoris of the Ischemic Cardiopathy and Coronary Units Section of the Spanish Society of Cardiology].
abstract: Medical treatment in angina pectoris is supported by: 1) slowing in coronary artery disease progression; 2) control of the angina episodes and the enhanced of the functional status, and, 3) prognosis improvement. The authors describe in this review, inside the own experience and the large body of evidence, the general measures and pharmacological treatment of both stable and unstable angina. There are included some therapeutic options in associated clinical conditions.
authors.forename: C
authors.initials: C
authors.lastname: Martín Luengo
authors.forename: M
authors.initials: M
authors.lastname: Abeytua Jiménez
authors.forename: X
authors.initials: X
authors.lastname: Bosch Genover
authors.forename: L
authors.initials: L
authors.lastname: López Bescós
authors.forename: J
authors.initials: J
authors.lastname: Tamargo Menéndez
authors.forename: A
authors.initials: A
authors.lastname: Tobaruela González
authors.forename: V
authors.initials: V
authors.lastname: Valle Tudela
mesh_terms: D000787:Angina Pectoris / Q000188:drug therapy* / Q000517:prevention & control; D000789:Angina, Unstable / Q000188:drug therapy / Q000517:prevention & control; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D005082:Physical Exertion; D012307:Risk Factors
vernacular_title: Tratamiento médico de la angina de pecho. Grupo de Estudio de Angina de Pecho de la Sección de Cardiopatía Isquémica y Unidades Coronarias de la Sociedad Española de Cardiología.